Report Detail

Other Global Artemisinin Derivatives Market Insights, Forecast to 2025

  • RnM2413473
  • |
  • 22 April, 2019
  • |
  • Global
  • |
  • 118 Pages
  • |
  • QYResearch
  • |
  • Other

Global Artemisinin Derivatives market size will increase to Million US$ by 2025, from Million US$ in 2018, at a CAGR of during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Artemisinin Derivatives.

This report researches the worldwide Artemisinin Derivatives market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global Artemisinin Derivatives breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

The following manufacturers are covered in this report:
Sanofi
KPC Pharmaceuticals
Guangxi Xiancaotang Pharmaceutical
Guilin Pharmaceutical
Kerui Nanhai Pharmaceutical
Shanghai Natural Bio-engineering Co
Novanat Bioresource
Botanical Extracts EPZ Ltd

Artemisinin Derivatives Breakdown Data by Type
Dihydroartemisinin
Artemisunate
Others
Artemisinin Derivatives Breakdown Data by Application
Malaria Treatment
Scientific Research
Others

Artemisinin Derivatives Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions

Artemisinin Derivatives Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa

The study objectives are:
To analyze and research the global Artemisinin Derivatives capacity, production, value, consumption, status and forecast;
To focus on the key Artemisinin Derivatives manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Artemisinin Derivatives :
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    Global Artemisinin Derivatives Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications

      1 Study Coverage

      • 1.1 Artemisinin Derivatives Product
      • 1.2 Key Market Segments in This Study
      • 1.3 Key Manufacturers Covered
      • 1.4 Market by Type
        • 1.4.1 Global Artemisinin Derivatives Market Size Growth Rate by Type
        • 1.4.2 Dihydroartemisinin
        • 1.4.3 Artemisunate
        • 1.4.4 Others
      • 1.5 Market by Application
        • 1.5.1 Global Artemisinin Derivatives Market Size Growth Rate by Application
        • 1.5.2 Malaria Treatment
        • 1.5.3 Scientific Research
        • 1.5.4 Others
      • 1.6 Study Objectives
      • 1.7 Years Considered

      2 Executive Summary

      • 2.1 Global Artemisinin Derivatives Production
        • 2.1.1 Global Artemisinin Derivatives Revenue 2014-2025
        • 2.1.2 Global Artemisinin Derivatives Production 2014-2025
        • 2.1.3 Global Artemisinin Derivatives Capacity 2014-2025
        • 2.1.4 Global Artemisinin Derivatives Marketing Pricing and Trends
      • 2.2 Artemisinin Derivatives Growth Rate (CAGR) 2019-2025
      • 2.3 Analysis of Competitive Landscape
        • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        • 2.3.2 Key Artemisinin Derivatives Manufacturers
      • 2.4 Market Drivers, Trends and Issues
      • 2.5 Macroscopic Indicator
        • 2.5.1 GDP for Major Regions
        • 2.5.2 Price of Raw Materials in Dollars: Evolution

      3 Market Size by Manufacturers

      • 3.1 Artemisinin Derivatives Production by Manufacturers
        • 3.1.1 Artemisinin Derivatives Production by Manufacturers
        • 3.1.2 Artemisinin Derivatives Production Market Share by Manufacturers
      • 3.2 Artemisinin Derivatives Revenue by Manufacturers
        • 3.2.1 Artemisinin Derivatives Revenue by Manufacturers (2014-2019)
        • 3.2.2 Artemisinin Derivatives Revenue Share by Manufacturers (2014-2019)
      • 3.3 Artemisinin Derivatives Price by Manufacturers
      • 3.4 Mergers & Acquisitions, Expansion Plans

      4 Artemisinin Derivatives Production by Regions

      • 4.1 Global Artemisinin Derivatives Production by Regions
        • 4.1.1 Global Artemisinin Derivatives Production Market Share by Regions
        • 4.1.2 Global Artemisinin Derivatives Revenue Market Share by Regions
      • 4.2 United States
        • 4.2.1 United States Artemisinin Derivatives Production
        • 4.2.2 United States Artemisinin Derivatives Revenue
        • 4.2.3 Key Players in United States
        • 4.2.4 United States Artemisinin Derivatives Import & Export
      • 4.3 Europe
        • 4.3.1 Europe Artemisinin Derivatives Production
        • 4.3.2 Europe Artemisinin Derivatives Revenue
        • 4.3.3 Key Players in Europe
        • 4.3.4 Europe Artemisinin Derivatives Import & Export
      • 4.4 China
        • 4.4.1 China Artemisinin Derivatives Production
        • 4.4.2 China Artemisinin Derivatives Revenue
        • 4.4.3 Key Players in China
        • 4.4.4 China Artemisinin Derivatives Import & Export
      • 4.5 Japan
        • 4.5.1 Japan Artemisinin Derivatives Production
        • 4.5.2 Japan Artemisinin Derivatives Revenue
        • 4.5.3 Key Players in Japan
        • 4.5.4 Japan Artemisinin Derivatives Import & Export
      • 4.6 Other Regions
        • 4.6.1 South Korea
        • 4.6.2 India
        • 4.6.3 Southeast Asia

      5 Artemisinin Derivatives Consumption by Regions

      • 5.1 Global Artemisinin Derivatives Consumption by Regions
        • 5.1.1 Global Artemisinin Derivatives Consumption by Regions
        • 5.1.2 Global Artemisinin Derivatives Consumption Market Share by Regions
      • 5.2 North America
        • 5.2.1 North America Artemisinin Derivatives Consumption by Application
        • 5.2.2 North America Artemisinin Derivatives Consumption by Countries
        • 5.2.3 United States
        • 5.2.4 Canada
        • 5.2.5 Mexico
      • 5.3 Europe
        • 5.3.1 Europe Artemisinin Derivatives Consumption by Application
        • 5.3.2 Europe Artemisinin Derivatives Consumption by Countries
        • 5.3.3 Germany
        • 5.3.4 France
        • 5.3.5 UK
        • 5.3.6 Italy
        • 5.3.7 Russia
      • 5.4 Asia Pacific
        • 5.4.1 Asia Pacific Artemisinin Derivatives Consumption by Application
        • 5.4.2 Asia Pacific Artemisinin Derivatives Consumption by Countries
        • 5.4.3 China
        • 5.4.4 Japan
        • 5.4.5 South Korea
        • 5.4.6 India
        • 5.4.7 Australia
        • 5.4.8 Indonesia
        • 5.4.9 Thailand
        • 5.4.10 Malaysia
        • 5.4.11 Philippines
        • 5.4.12 Vietnam
      • 5.5 Central & South America
        • 5.5.1 Central & South America Artemisinin Derivatives Consumption by Application
        • 5.5.2 Central & South America Artemisinin Derivatives Consumption by Countries
        • 5.5.3 Brazil
      • 5.6 Middle East and Africa
        • 5.6.1 Middle East and Africa Artemisinin Derivatives Consumption by Application
        • 5.6.2 Middle East and Africa Artemisinin Derivatives Consumption by Countries
        • 5.6.3 Turkey
        • 5.6.4 GCC Countries
        • 5.6.5 Egypt
        • 5.6.6 South Africa

      6 Market Size by Type

      • 6.1 Global Artemisinin Derivatives Breakdown Dada by Type
      • 6.2 Global Artemisinin Derivatives Revenue by Type
      • 6.3 Artemisinin Derivatives Price by Type

      7 Market Size by Application

      • 7.1 Overview
      • 7.2 Global Artemisinin Derivatives Breakdown Dada by Application
        • 7.2.1 Global Artemisinin Derivatives Consumption by Application
        • 7.2.2 Global Artemisinin Derivatives Consumption Market Share by Application (2014-2019)

      8 Manufacturers Profiles

      • 8.1 Sanofi
        • 8.1.1 Sanofi Company Details
        • 8.1.2 Company Description
        • 8.1.3 Capacity, Production and Value of Artemisinin Derivatives
        • 8.1.4 Artemisinin Derivatives Product Description
        • 8.1.5 SWOT Analysis
      • 8.2 KPC Pharmaceuticals
        • 8.2.1 KPC Pharmaceuticals Company Details
        • 8.2.2 Company Description
        • 8.2.3 Capacity, Production and Value of Artemisinin Derivatives
        • 8.2.4 Artemisinin Derivatives Product Description
        • 8.2.5 SWOT Analysis
      • 8.3 Guangxi Xiancaotang Pharmaceutical
        • 8.3.1 Guangxi Xiancaotang Pharmaceutical Company Details
        • 8.3.2 Company Description
        • 8.3.3 Capacity, Production and Value of Artemisinin Derivatives
        • 8.3.4 Artemisinin Derivatives Product Description
        • 8.3.5 SWOT Analysis
      • 8.4 Guilin Pharmaceutical
        • 8.4.1 Guilin Pharmaceutical Company Details
        • 8.4.2 Company Description
        • 8.4.3 Capacity, Production and Value of Artemisinin Derivatives
        • 8.4.4 Artemisinin Derivatives Product Description
        • 8.4.5 SWOT Analysis
      • 8.5 Kerui Nanhai Pharmaceutical
        • 8.5.1 Kerui Nanhai Pharmaceutical Company Details
        • 8.5.2 Company Description
        • 8.5.3 Capacity, Production and Value of Artemisinin Derivatives
        • 8.5.4 Artemisinin Derivatives Product Description
        • 8.5.5 SWOT Analysis
      • 8.6 Shanghai Natural Bio-engineering Co
        • 8.6.1 Shanghai Natural Bio-engineering Co Company Details
        • 8.6.2 Company Description
        • 8.6.3 Capacity, Production and Value of Artemisinin Derivatives
        • 8.6.4 Artemisinin Derivatives Product Description
        • 8.6.5 SWOT Analysis
      • 8.7 Novanat Bioresource
        • 8.7.1 Novanat Bioresource Company Details
        • 8.7.2 Company Description
        • 8.7.3 Capacity, Production and Value of Artemisinin Derivatives
        • 8.7.4 Artemisinin Derivatives Product Description
        • 8.7.5 SWOT Analysis
      • 8.8 Botanical Extracts EPZ Ltd
        • 8.8.1 Botanical Extracts EPZ Ltd Company Details
        • 8.8.2 Company Description
        • 8.8.3 Capacity, Production and Value of Artemisinin Derivatives
        • 8.8.4 Artemisinin Derivatives Product Description
        • 8.8.5 SWOT Analysis

      9 Production Forecasts

      • 9.1 Artemisinin Derivatives Production and Revenue Forecast
        • 9.1.1 Global Artemisinin Derivatives Production Forecast 2019-2025
        • 9.1.2 Global Artemisinin Derivatives Revenue Forecast 2019-2025
      • 9.2 Artemisinin Derivatives Production and Revenue Forecast by Regions
        • 9.2.1 Global Artemisinin Derivatives Revenue Forecast by Regions
        • 9.2.2 Global Artemisinin Derivatives Production Forecast by Regions
      • 9.3 Artemisinin Derivatives Key Producers Forecast
        • 9.3.1 United States
        • 9.3.2 Europe
        • 9.3.3 China
        • 9.3.4 Japan
      • 9.4 Forecast by Type
        • 9.4.1 Global Artemisinin Derivatives Production Forecast by Type
        • 9.4.2 Global Artemisinin Derivatives Revenue Forecast by Type

      10 Consumption Forecast

      • 10.1 Consumption Forecast by Application
      • 10.2 Artemisinin Derivatives Consumption Forecast by Regions
      • 10.3 North America Market Consumption Forecast
        • 10.3.1 North America Artemisinin Derivatives Consumption Forecast by Countries 2019-2025
        • 10.3.2 United States
        • 10.3.3 Canada
        • 10.3.4 Mexico
      • 10.4 Europe Market Consumption Forecast
        • 10.4.1 Europe Artemisinin Derivatives Consumption Forecast by Countries 2019-2025
        • 10.4.2 Germany
        • 10.4.3 France
        • 10.4.4 UK
        • 10.4.5 Italy
        • 10.4.6 Russia
      • 10.5 Asia Pacific Market Consumption Forecast
        • 10.5.1 Asia Pacific Artemisinin Derivatives Consumption Forecast by Countries 2019-2025
        • 10.5.2 China
        • 10.5.3 Japan
        • 10.5.4 Korea
        • 10.5.5 India
        • 10.5.6 Australia
        • 10.5.7 Indonesia
        • 10.5.8 Thailand
        • 10.5.9 Malaysia
        • 10.5.10 Philippines
        • 10.5.11 Vietnam
      • 10.6 Central & South America Market Consumption Forecast
        • 10.6.1 Central & South America Artemisinin Derivatives Consumption Forecast by Country 2019-2025
        • 10.6.2 Brazil
      • 10.7 Middle East and Africa Market Consumption Forecast
        • 10.7.1 Middle East and Africa Artemisinin Derivatives Consumption Forecast by Countries 2019-2025
        • 10.7.2 Middle East and Africa
        • 10.7.3 Turkey
        • 10.7.4 GCC Countries
        • 10.7.5 Egypt
        • 10.7.6 South Africa

      11 Upstream, Industry Chain and Downstream Customers Analysis

      • 11.1 Analysis of Artemisinin Derivatives Upstream Market
        • 11.1.1 Artemisinin Derivatives Key Raw Material
        • 11.1.2 Typical Suppliers of Key Artemisinin Derivatives Raw Material
        • 11.1.3 Artemisinin Derivatives Raw Material Market Concentration Rate
      • 11.2 Artemisinin Derivatives Industry Chain Analysis
      • 11.3 Marketing & Distribution
      • 11.4 Artemisinin Derivatives Distributors
      • 11.5 Artemisinin Derivatives Customers

      12 Opportunities & Challenges, Threat and Affecting Factors

      • 12.1 Market Opportunities
      • 12.2 Market Challenges
      • 12.3 Porter's Five Forces Analysis

      13 Key Findings

        14 Appendix

        • 14.1 Research Methodology
          • 14.1.1 Methodology/Research Approach
          • 14.1.2 Data Source
        • 14.2 Author Details

        Summary:
        Get latest Market Research Reports on Artemisinin Derivatives . Industry analysis & Market Report on Artemisinin Derivatives is a syndicated market report, published as Global Artemisinin Derivatives Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Artemisinin Derivatives market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,900.00
        $5,850.00
        $7,800.00
        3,108.30
        4,662.45
        6,216.60
        3,627.00
        5,440.50
        7,254.00
        596,232.00
        894,348.00
        1,192,464.00
        325,377.00
        488,065.50
        650,754.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report